An in-depth look to MEDIGEN VACCINE BIOLOGICS CORPORATE operating, investing, and financing activities

6547 free cash flow for Q3 24 is -5.18 M TWD. For 2023, 6547 free cash flow was -516.44 M TWD and operating cash flow was -477.75 M TWD.